Teladoc Health (TDOC) Return on Capital Employed (2015 - 2026)

Teladoc Health has disclosed Return on Capital Employed across 12 years of filings, most recently posting 8.41% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 8.41%, up 3330.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8.41% (up 3330.0% YoY), and the FY2025 annual result was 9.45%, up 2443.0% from the prior year.
• Return on Capital Employed came in at 8.41% for Q1 2026 at Teladoc Health, up from 10.67% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 6.31% in Q4 2023 to a low of 234.39% in Q4 2022.
• The 5-year median for Return on Capital Employed is 39.55% (2024), against an average of 65.29%.
• Across the five-year window, Return on Capital Employed tumbled 23286 bps in 2022 and surged 22809 bps in 2023, its largest moves.
• Teladoc Health's Return on Capital Employed stood at 234.39% in 2022, then jumped by 97 bps to 6.31% in 2023, then plunged by 527 bps to 39.55% in 2024, then surged by 73 bps to 10.67% in 2025, then gained by 21 bps to 8.41% in 2026.
• The last three Return on Capital Employed figures came in at 8.41% (Q1 2026), 10.67% (Q4 2025), and 11.09% (Q3 2025), per Business Quant data.